Integrating China in the International Consortium for Personalised Medicine: a position paper on innovation and digitalization in Personalized Medicine

Flavia Beccia,Marzia Di Marcantonio,Francesco Andrea Causio,Lena Schleicher,Lili Wang,Chiara Cadeddu,Walter Ricciardi,Stefania Boccia

DOI: https://doi.org/10.1186/s12889-024-18009-8

IF: 4.5

2024-02-17

BMC Public Health

Abstract:The advent of Personalized Medicine (PM) holds significant promise in revolutionizing healthcare by tailoring treatments to individual patients based on their data. However, its successful implementation requires the seamless integration of innovative technologies and presents formidable challenges in terms of sustainability. To tackle these challenges head-on, the International Consortium for Personalized Medicine (ICPerMed) was established, and the IC2PerMed project, as part of this consortium, seeks to foster collaboration between the European Union (EU) and China in the field of Personalized Medicine. Based on the results collected by the project, the objective of this study is to discern the key priorities for the implementation of Personalised Medicine concerning Information and Communication Technologies (ICT) and Big Data and digital solutions, with a particular emphasis on data management and protection.

public, environmental & occupational health

What problem does this paper attempt to address?

The main issue this paper attempts to address is the technical, policy, and social challenges faced in the implementation of Personalized Medicine (PM). Specifically, through the Delphi survey method of international experts, the paper aims to identify and determine the key priorities for EU-China cooperation in advancing personalized medicine in the fields of Information and Communication Technology (ICT) and big data solutions, as well as in the process of bringing innovative results to market. These priorities cover various aspects such as data interoperability, standardization, data security measures, international cooperation, cost-effectiveness analysis, etc., to promote the sustainable development and innovative application of personalized medicine on a global scale.

The focus of the paper includes:
1. **Data Interoperability and Standardization**: Ensuring that data from different sources can be effectively combined and used, improving data accessibility and usability.
2. **Data Security Measures**: Ensuring that citizens' ownership and privacy rights are protected when handling health data, while complying with existing data protection regulations.
3. **Global Cooperation and Policy Making**: Promoting global cooperation, creating secure data-sharing zones, and fostering collaboration between academia and industry.
4. **Economic Costs and Market Access Barriers**: Reducing the economic costs of personalized diagnostics, lowering market access barriers, and ensuring that innovative personalized medical solutions can be widely adopted.
5. **Consideration of Social and Cultural Differences**: Respecting the social and cultural differences of different countries and protecting public trust in government and national institutions.

By identifying these priorities, the paper hopes to provide guidance for EU-China cooperation in the field of personalized medicine, promoting technological innovation and the sustainable development of medical systems.